Antinociceptive, muscle relaxant and sedative activities of gold nanoparticles generated by methanolic extract of Euphorbia milii

BMC Complementary and Alternative Medicine

Volumn 15, Issue 1, 2015, Pages

  Islam, Nazar Ul ^a,b   Khan, Ibrahim ^b   Rauf, Abdur ^b   Muhammad, Naveed ^c   Shahid, Muhammad ^a   Shah, Mohammad Raza ^d  

^a Sarhad University of Science Information Technology   (Pakistan)

^b UNIVERSITY OF PESHAWAR   (Pakistan)

^c ABDUL WALI KHAN UNIVERSITY   (Pakistan)

^d UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

Antinociceptive; Euphorbia milii; Gold nanoparticles; Herbal drugs; Muscle relaxant; Nanotechnology; Sedative

Indexed keywords

COBALT; COPPER; DIAZEPAM; DICLOFENAC; EUPHORBIA MILII METHANOLIC EXTRACT; GOLD DERIVATIVE; GOLD NANOPARTICLE; HEAVY METAL; LEAD; MERCURY; METHANOL; NICKEL; PLANT EXTRACT; REDUCING AGENT; SODIUM CHLORIDE; TETRACHLOROAURATE TRIHYDRATE; UNCLASSIFIED DRUG; ANALGESIC AGENT; CENTRAL MUSCLE RELAXANT; CHLORIDE; DRUG CARRIER; GOLD; GOLD TETRACHLORIDE, ACID; HYPNOTIC SEDATIVE AGENT; NANOPARTICLE;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; ATOMIC FORCE MICROSCOPY; CONTROLLED STUDY; DRUG EFFECT; DRUG SENSITIVITY; DRUG STABILITY; DRUG SYNTHESIS; EUPHORBIA; EUPHORBIA MILII; INFRARED SPECTROPHOTOMETRY; MEDICINAL PLANT; MOUSE; MUSCLE RELAXATION; NONHUMAN; OPEN FIELD TEST; PH; ROTAROD TEST; SCANNING ELECTRON MICROSCOPY; SEDATION; ULTRAVIOLET SPECTROSCOPY; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; FEMALE; MALE; NANOTECHNOLOGY; PAIN; PHYTOTHERAPY;

ANALGESICS; ANIMALS; CHLORIDES; DRUG CARRIERS; DRUG STABILITY; EUPHORBIA; FEMALE; GOLD; GOLD COMPOUNDS; HYPNOTICS AND SEDATIVES; MALE; MICE, INBRED BALB C; MUSCLE RELAXANTS, CENTRAL; NANOPARTICLES; NANOTECHNOLOGY; PAIN; PHYTOTHERAPY; PLANT EXTRACTS;

EID: 84930210063     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/s12906-015-0691-7     Document Type: Article

References (67)

1. Ansari S, Farha IM. Influence of nanotechnology on herbal drugs: A Review. J Adv Pharm Technol Res. 2012;3(3):142-6.
2. Csermely P, Agoston V, Pongor S. The efficiency of multi-target drugs: the network approach might help drug design. Trends Pharmacol Sci. 2005;26(4):178-82.
3. X-y T, Liu L. Drug discovery enters a new era with multi-target intervention strategy. Chin J Integr Med. 2012;18:539-42.
4. Bonifácio BV, da Silva PB. Nanotechnology-based drug delivery systems and herbal medicines: a review. Int J Nanomedicine. 2014;9:1-15.
5. Jiang W, Kim BY, Rutka JT, Chan WC. Advances and challenges of nanotechnology-based drug delivery systems. Expert Opin Drug Deliv. 2007;4(6):621-33.
6. Gunasekaran T, Haile T, Nigusse T, Dhanaraju MD. Nanotechnology: an effective tool for enhancing bioavailability and bioactivity of phytomedicine. Asian Pac J Trop Biomed. 2014;4 Suppl 1:S1-7.
7. Farokhzad OC, Langer R. Impact of nanotechnology on drug delivery. ACS Nano. 2009;3(1):16-20.
8. Mwine TJ, Van Damme P. Why do Euphorbiaceae tick as medicinal plants?: a review of Euphorbiaceae family and its medicinal features. J Med Plant Res. 2011;5(5):652-62.
9. Chaabi M, Freund-Michel V, Frossard N, Randriantsoa A, Andriantsitohaina R, Lobstein A. Anti-proliferative effect of Euphorbia stenoclada in human airway smooth muscle cells in culture. J Ethnopharmacol. 2007;109(1):134-9.
10. Mothana RA, Lindequist U, Gruenert R, Bednarski PJ. Studies of the in vitro anticancer, antimicrobial and antioxidant potentials of selected Yemeni medicinal plants from the island Soqotra. BMC Complement Altern Med. 2009;9(1):7.
11. Ravikanth V, Reddy VLN, Reddy AV, Ravinder K, Rao TP, Ram TS, et al. Three new ingol diterpenes from Euphorbia nivulia: evaluation of cytotoxic activity. Chem Pharm Bull (Tokyo). 2003;51(4):431-4.
12. Fatope MO, Zeng L, Ohayagha JE, McLaughlin JL. New 19-acetoxyingol diterpenes from the latex of Euphorbia poisonii (Euphorbiaceae). Bioorg Med Chem. 1996;4(10):1679-83.
13. Roe FJ, Peirce WE. Tumor promotion by Euphorbia latices. Cancer Res. 1961;21(3):338-44.
14. Sudhakar M, Rao CV, Rao P, Raju DB, Venkateswarlu Y. Antimicrobial activity of Caesalpinia pulcherrima, Euphorbia hirta and Asystasia gangeticum. Fitoterapia. 2006;77(5):378-80.
15. Natarajan D, Britto SJ, Srinivasan K, Nagamurugan N, Mohanasundari C, Perumal G. Anti-bacterial activity of Euphorbia fusiformis-A rare medicinal herb. J Ethnopharmacol. 2005;102(1):123-6.
16. Atta AH, Mouneir SM. Evaluation of some medicinal plant extracts for antidiarrhoeal activity. Phytother Res. 2005;19(6):481-5.
17. Williams LA, Gossell-Williams M, Sajabi A, Barton EN, Fleischhacker R. Angiotensin converting enzyme inhibiting and anti-dipsogenic activities of Euphorbia hirta extracts. Phytother Res. 1997;11(5):401-2.
18. Giovanelli A, Silva CLPAC, Medeiros L, Vasconcellos MC. The molluscicidal activity of the latex of Euphorbia splendens var. hislopii on Melanoides tuberculata (Thiaridae), a snail associated with habitats of Biomphalaria glabrata (Planorbidae). Mem Inst Oswaldo Cruz. 2001;96(1):123-5.
19. Zani CL, Marston A, Hamburger M, Hostettmann K. Molluscicidal milliamines from Euphorbia milii var. hislopii. Phytochemistry. 1993;34(1):89-95.
20. Ahmad VU, Hussain J, Hussain H, Jassbi AR, Ullah F, Lodhi MA, et al. First natural urease inhibitor from Euphorbia decipiens. Chem Pharm Bull (Tokyo). 2003;51(6):719-23.
21. Lanhers M-C, Fleurentin J, Dorfman P, Mortier F, Pelt J-M. Analgesic, antipyretic and anti-inflammatory properties of Euphorbia hirta. Planta Med. 1991;57(03):225-31.
22. Battu GR, Ethadi SR, Veda Priya G, Swathi Priya K, Chandrika K, Venkateswara Rao A, et al. Evaluation of antioxidant and anti-inflammatory activity of Euphorbia heyneana Spreng. Asian Pac J Trop Biomed. 2011;1(2):S191-S4.
23. Gaur K, Rana A, Nema R, Kori M, Sharma C. Anti-inflammatory and analgesic activity of hydro-alcoholic leaves extract of Euphorbia neriifolia Linn. Asian J Pharm Clin Res. 2009;2(1):26-8.
24. Ahmad VU, Hussain H, Bukhari IA, Hussain J, Jassbi AR, Dar A. Antinociceptive diterpene from Euphorbia decipiens. Fitoterapia. 2005;76(2):230-2.
25. Shi Q-W, Su X-H, Kiyota H. Chemical and pharmacological research of the plants in genus Euphorbia. Chem Rev. 2008;108(10):4295-327.
26. Ma Q-G, Liu W-Z, Wu X-Y, Zhou T-X, Qin G-W. Diterpenoids from Euphorbia fischeriana. Phytochemistry. 1997;44(4):663-6.
27. Appendino G, Szallasi A. Euphorbium: modern research on its active principle, resiniferatoxin, revives an ancient medicine. Life Sci. 1997;60(10):681-96.
28. Bani S, Suri K, Suri O, Sharma O. Analgesic and antipyretic properties of Euphorbia royleana latex. Phytother Res. 1997;11(8):597-9.
29. Vamsidhar I, Mohammed AH, Nataraj B, Rao CM, Ramesh M. Antinociceptive activity of Euphorbia heterophylla roots. Fitoterapia. 2000;71(5):562-3.
30. Rauf A, Muhammad N, Qaisar M, Uddin G, Hussain I. Preliminary Antinociceptive Studies of Methanol Extract of Euphorbia milli. Middle-East J Med Plants Res. 2012;1(3):68-70.
31. Manandhar NP, Sanjay M. Plants and people of Nepal. Portland, Oregon: Timber Press; 2002.
32. Delgado I, De-Carvalho R, De-Oliveira A, Kuriyama S, Oliveira-Filho E, Souza C, et al. Absence of tumor promoting activity of Euphorbia milii latex on the mouse back skin. Toxicol Lett. 2003;145(2):175-80.
33. Freitas J, Presgrave O, Fingola F, Menezes M, Vasconcellos M, Schall V, et al. Toxicological study of the molluscicidal latex of Euphorbia splendens: irritant action on skin and eye. Mem Inst Oswaldo Cruz. 1991;86:87-8.
34. Pancorbo S, Hammer RH. Preliminary phytochemical investigation of Euphorbia millii. J Pharm Sci. 1972;61(6):954-7.
35. Muhammad N, Saeed M, Khan H. Antipyretic, analgesic and anti-inflammatory activity of Viola betonicifolia whole plant. BMC Complement Altern Med. 2012;12(1):59-66.
36. Muhammad N, Saeed M, Khan H, Haq I. Evaluation of n-hexane extract of Viola betonicifolia for its neuropharmacological properties. J Nat Med. 2013;67(1):1-8.
37. Goyal M, Nagori B, Sasmal D. Sedative and anticonvulsant effects of an alcoholic extract of Capparis decidua. J Nat Med. 2009;63(4):375-9.
38. Wagner V, Dullaart A, Bock A-K, Zweck A. The emerging nanomedicine landscape. Nat Biotechnol. 2006;24(10):1211-8.
39. Bogunia-Kubik K, Sugisaka M. From molecular biology to nanotechnology and nanomedicine. Biosystems. 2002;65(2):123-38.
40. Yadav D, Suri S, Choudhary A, Sikender M, Hemant BN. Novel approach: Herbal remedies and natural products in pharmaceutical science as nano drug delivery systems. Int J Pharm Tech. 2011;3(3):3092-116.
41. Khare CP. Indian herbal remedies: rational Western therapy, ayurvedic, and other traditional usage, Botany. Springer Science & Business Media; 2003.
42. Sharma GD, Tripathi S. Experimental evaluation of dugdhika (Euphorbia prostrata w. Ait) for the treatment of 'tamaka svasa'(bronchial asthma). Anc Sci Life. 1984;3(3):143.
43. Bakhshi GD, Langade DG, Desai VS. Prospective, Open Label Study of Euphorbia Prostrata Extract 100mg in the Treatment of Bleeding Haemorrhoids. Bombay Hosp J. 2008;50(4):577-83.
44. Gupta P. The efficacy of Euphorbia prostrata in early grades of symptomatic hemorrhoids-a pilot study. Eur Rev Med Pharmacol Sci. 2011;15(2):199-203.
45. Cruz C, Kasper P, Cataldo A, Zamith H, Paumgartten F. Tumor promoter-like activity of the molluscicidal latex of 'Crown-of-Thorns' (Euphorbia milii var. hislopii) in the V79 metabolic cooperation assay. Braz J Med Biol Res. 1996;29(11):1519-23.
46. Vogg G, Mattes E, Rothenburger J, Hertkorn N, Achatz S, Sandermann H. Tumor promoting diterpenes from Euphorbia leuconeura L. Phytochemistry. 1999;51(2):289-95.
47. Norhanom A, Yadav M. Tumour promoter activity in Malaysian Euphorbiaceae. Br J Cancer. 1995;71(4):776-9.
48. Ghosh P, Han G, De M, Kim CK, Rotello VM. Gold nanoparticles in delivery applications. Adv Drug Deliv Rev. 2008;60(11):1307-15.
49. Lasagna-Reeves C, Gonzalez-Romero D, Barria M, Olmedo I, Clos A, Ramanujam VS, et al. Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice. Biochem Biophys Res Commun. 2010;393(4):649-55.
50. de Matos RA, Cordeiro TS, Samad RE, Vieira Jr. ND, Courrol LC. Green synthesis of stable silver nanoparticles using Euphorbia milii latex. Colloids Surf A Physicochem Eng Asp. 2011;389(1):134-7.
51. Valodkar M, Jadeja RN, Thounaojam MC, Devkar RV, Thakore S. Biocompatible synthesis of peptide capped copper nanoparticles and their biological effect on tumor cells. Mater Chem Phys. 2011;128(1):83-9.
52. Lin Z, Wu J, Xue R, Yang Y. Spectroscopic characterization of Au3+ biosorption by waste biomass of Saccharomyces cerevisiae. Spectrochim Acta A Mol Biomol Spectrosc. 2005;61(4):761-5.
53. Qaisar M, NaeemuddinGilani S, Farooq S. Preliminary Comparative Phytochemical Screening of Euphorbia Species. Amer-Eurasian J Agri & Environ Sci. 2012;12(8):1056-60.
54. Zhang Y, Chen Y, Westerhoff P, Crittenden J. Impact of natural organic matter and divalent cations on the stability of aqueous nanoparticles. Water Res. 2009;43(17):4249-57.
55. Gao W, Chan JM, Farokhzad OC. pH-responsive nanoparticles for drug delivery. Mol Pharm. 2010;7(6):1913-20.
56. Langer K, Balthasar S, Vogel V, Dinauer N, Von Briesen H, Schubert D. Optimization of the preparation process for human serum albumin (HSA) nanoparticles. Int J Pharm. 2003;257(1):169-80.
57. Auffan M, Rose J, Wiesner MR, Bottero J-Y. Chemical stability of metallic nanoparticles: a parameter controlling their potential cellular toxicity in vitro. Environ Pollut. 2009;157(4):1127-33.
58. Murphy CJ, Gole AM, Hunyadi SE, Stone JW, Sisco PN, Alkilany A, et al. Chemical sensing and imaging with metallic nanorods. Chem Commun. 2008;5:544-57.
59. Qu X, Alvarez PJ, Li Q. Applications of nanotechnology in water and wastewater treatment. Water Res. 2013;47(12):3931-46.
60. Järup L. Hazards of heavy metal contamination. Br Med Bull. 2003;68(1):167-82.
61. Garvey GJ, Hahn G, Lee RV, Harbison RD. Heavy metal hazards of Asian traditional remedies. Int J Environ Heal R. 2001;11(1):63-71.
62. Sahoo N, Manchikanti P, Dey S. Herbal drugs: standards and regulation. Fitoterapia. 2010;81(6):462-71.
63. Gerhardt A, Mcgraw NR, Schwartz DK, Bee JS, Carpenter JF, Randolph TW. Protein aggregation and particle formation in prefilled glass syringes. J Pharm Sci. 2014;103(6):1601-12.
64. Fradkin AH, Carpenter JF, Randolph TW. Glass particles as an adjuvant: a model for adverse immunogenicity of therapeutic proteins. J Pharm Sci. 2011;100(11):4953-64.
65. Matsumoto H, Naraba H, Ueno A, Fujiyoshi T, Murakami M, Kudo I, et al. Induction of cyclooxygenase-2 causes an enhancement of writhing response in mice. Eur J Pharmacol. 1998;352(1):47-52.
66. Dey P, Chandra S, Chatterjee P, Bhattacharya S. Neuropharmacological properties of Mikania scandens (L.) Willd.(Asteraceae). J Adv Pharm Technol Res. 2011;2(4):255-9.
67. Kaur R, Jaggi AS, Singh N. Studies on EŠect of Stress Preconditioning in Restrain Stress-induced Behavioral Alterations. Yakugaku Zasshi. 2010;130(2):215-21.